Skip to Page Content
Home  |  Contact Us  |  Press Room  |  Site Overview  |  Help  |  Login  |  Register
Add to MyNCSL

MAT Logo

MAT Newsletters

NCSL's MAT Newsletter is a monthly electronic newsletter reporting on medication-assisted treatment for opiate addiction and the public financing of that treatment.  The MAT Newsletter is sent out to a listserv and published online.  To be added to the listserv, click here to subscribe now.

Issues

2008: March | April | May | June | July | August | September | October | November |

2008

March

  • Boston Studies of Buprenorphine
  • DEA Advisory on Methadone Tablets
  • New Mexico Provides Narcan Nasal Spray
  • Addiction Genes Identified

April

  • Federal  Buprenorphine Strategy
  • Pay for Performance Improves Treatment Outcomes
  • Prescription Abuse on Campus
  • Treatment Up for Opiate Abusers
May
  • Indiana Increases Opioid Clinic Regulations
  • Methadone Internationally 
  • More Workers Testing Positive for Opiates
  • How Doctors Can Stem Opiate Abuse

June

  • Requiring Pre-Approval of Buprenorphine
  • More Treatment Facilities in Massachusetts
  • Training Users in Overdose Prevention

July

  • Heroin Abuse on the Rise in the Empire State
  • Study Rates Buprenorphine Best Treatment for Opiates
  • Treatment Lacking in Alaska
  • Naltrexone Shows Potential for Other Conditions
  • Opiates Leading Cause of Death in Florida
  • Money Diverted from Virginia Treatment Programs   

August

  • Opioid Treatment Almost Nonexistent in Rural Areas 
  • Treatment Completion Rates Lower for Opiate Users 
  • The Costs of Under-Treating Addiction
  • Methadone in the Suburbs  
  • Perscription Pain Abuse at the Local Level  
September
  • HIV Survival Rates in IV Drug Users
  • Methadone as Treatment for Lukemia
  • Russia Scorns Methadone, Embraces Nalrexone
  • SAMHSA To Fund Opiate Training

October

  • A New and Improved Oxycontin
  • Drug Use Steady Overall, but More Using Opiate Pain Meds
  • Modified Naltrexone May Aid in Long-Term Recovery

November 

  • Buprenorphine as Neonatal Treatment, Pain Killer
  • Cough Syrup as Heroin Treatment
  • Most Who Need Drug Treatment Not Receiving
  • Feds Pass Substance Abuse Parity

Denver Office: Tel: 303-364-7700 | Fax: 303-364-7800 | 7700 East First Place | Denver, CO 80230 | Map
Washington Office: Tel: 202-624-5400 | Fax: 202-737-1069 | 444 North Capitol Street, N.W., Suite 515 | Washington, D.C. 20001